BofA lowered the firm’s price target on Keurig Dr Pepper to $37 from $45 and keeps a Buy rating on the shares. The firm is adjusting price objectives for several names in U.S. Consumer Staples to reflect rates and revised estimates. In the firm’s view, Q3 earnings season has “limited surprise potential” compared to the first half, with positive revision potential seen being highest for Household Product Personal Care, Beverages “more modest,” and Packaged Food “more of a mixed bag given volume weakness,” the analyst tells investors in a preview note.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on KDP:
- Keurig Dr Pepper price target lowered to $34 from $40 at Barclays
- Keurig Dr Pepper price target lowered to $37 from $40 at Bernstein
- Keurig Dr Pepper price target lowered to $33 from $37 at Citi
- Keurig Dr Pepper call volume above normal and directionally bullish
- Keurig Dr Pepper names Tim Cofer as COO, will assume CEO role in 2Q 2024